Abstract:In addition to the well-known use of microbubbles (MBs) as powerful contrast agents for general tissue delineation and perfusion in ultrasound (US) imaging, US-targeted MB destruction (UTMD) has been demonstrated to be an emerging technique for noninvasive drug delivery to tumor sites. However, the very limited drug-loading capacity of conventional MBs remains a great obstacle to their application as an efficacious cancer therapy. In this study, an amphiphilic Janus camptothecin-floxuridine (CF) conjugate was synthesized to engineer CF MBs with ultrahigh drug-loading contents (up to 56.7 ± 2.3%). CF MBs were proven to be an excellent contrast agent to enhance US imaging for identifying the location and size of tumors. Upon local US exposure to burst CF MBs under the guidance of contrast-enhanced US imaging, successful conversion of CF MBs into CF NPs in situ resulted in ~14 times higher drug accumulation of the CF conjugate via the sonoporation effect than that of CF NPs and CF MBs without US. After CF was internalized by tumor cells and its ester bond was hydrolyzed, camptothecin (CPT) and floxuridine (FUDR) were released at an exact 1:1 ratio to achieve coordinated pharmacokinetics, leading to significantly higher tumor growth inhibition in murine tumor models of CF MBs combined with US (~72.4%) than CF NPs (~54.1%) and liposomes loaded with CPT and FUDR (~21.6%). Overall, these results demonstrate that the combination of CF MBs with US is a powerful strategy for remarkably enhancing the combined chemotherapeutic efficacy and greatly reducing the undesirable side effects. Tiny gas-filled bubbles that help microscopes spot tumors can also deliver drug nanoparticles to tumor cells. Microbubbles have resonant properties that enhance the quality of ultrasonic images, and are safe to introduce into the bloodstream. Zhifei Dai from Peking University in Beijing, China, and co-workers have now developed a synthetic procedure that combines two promising anticancer drugs in a complex that spontaneously forms microbubbles following mechanical agitation with a fluorinated gas. Ultrasound imaging demonstrated that these microbubbles could be tracked as they circulated to tumor sites in mice. Then, using minute-long ultrasound applications, the team burst the bubbles and created drug nanoparticles. Therapeutic studies revealed that the ultrasound waves facilitated drug movement across tumor cell membranes, leading to lower rates of tumor growth compared to intravenous injections of the nanoparticles. Amphiphilic Janus camptothecin-floxuridine (CF) conjugate was synthesized for engineering CF microbubbles (CF MBs) with ultrahigh drug-loading contents. CF MBs exhibited excellent capability to enhance ultrasound (US) imaging for identifying the location and size of the tumors, while it can be efficiently converted into CF NPs upon sonication, conducing to remarkably high drug tumor accumulation via sonoporation effect. Both camptothecin (CPT) and floxuridine (FUDR) could be released at an exact 1:1 ratio in the tumor microenvironment, achieving significantly improved therapeutic efficacy. Overall, the CF MBs combining with US technique will provide a step toward the application of targeted theranostics.

Ultrasound-mediated multifunctional magnetic microbubbles for drug delivery of celastrol in VX2 liver transplant tumors

Preparation and Antitumor Activity of Bfgf-Mediated Active Targeting Doxorubicin Microbubbles

Anti-tumor Efficacy of Ultrasonic Cavitation is Potentiated by Concurrent Delivery of Anti-Angiogenic Drug in Colon Cancer

Magnetic Targeting and Ultrasound Activation of Liposome-Microbubble Conjugate for Enhanced Delivery of Anti-Cancer Therapies.

Injectable PLGA/Fe3O4 implants carrying cisplatin for synergistic magnetic hyperthermal ablation of rabbit VX2 tumor

Feasibility of Using 3D Contrast Enhanced Ultrasound Technology to Predict the Treatment Effect of Targeted Drugs-Loaded Thermosensitive Hydrogel Therapy on the Rabbit Vx2 Tumor Model

High-Performance Poly(lactic-co-glycolic Acid)-Magnetic Microspheres Prepared by Rotating Membrane Emulsification for Transcatheter Arterial Embolization and Magnetic Ablation in VX2 Liver Tumors.

Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer

Magnetic Nanoliposomes As in Situ Microbubble Bombers for Multimodality Image-Guided Cancer Theranostics.

A Novel Magnetic Nanoparticle Hyperthermia Combined with Acmf-Dependant Drug Release by Damms Injection in Vx-2 Liver Tumors

Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional Therapy

Synthesis and in vitro experiments of carcinoma vascular endothelial targeting polymeric nano-micelles combining small particle size and supermagnetic sensitivity

Multifunctional Fe3O4@SiO2-CDs magnetic fluorescent nanoparticles as effective carrier of gambogic acid for inhibiting VX2 tumor cells

Preparation of microspheres encapsulating sorafenib and catalase and their application in rabbit VX2 liver tumor

Low-intensity focused ultrasound-augmented Cascade chemodynamic therapy via boosting ROS generation

Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer

Ultrasound-visualized, site-specific vascular embolization using magnetic protein microcapsules

Doxorubicin Loaded Superparamagnetic PLGA-iron Oxide Multifunctional Microbubbles for Dual-Mode US/MR Imaging and Therapy of Metastasis in Lymph Nodes

Impact of particle size of multivesicular liposomes on the embolic and therapeutic effects in rabbit VX2 liver tumor

Active targeted dual-modal CT/MR imaging of VX2 tumors using PEGylated BaGdF5 nanoparticles conjugated with RGD

Ultrasound Contrast Agent Microbubbles with Ultrahigh Loading Capacity of Camptothecin and Floxuridine for Enhancing Tumor Accumulation and Combined Chemotherapeutic Efficacy